Prospective evaluation of the utility of the serum free light chain assay (FLC), clonal Ig V(L) gene identification and troponin I levels in a phase II trial of risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis Conference Paper
| Authors: | Comenzo, R. L.; Zhou, P.; Reich, L.; Costello, S.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M. |
| Title: | Prospective evaluation of the utility of the serum free light chain assay (FLC), clonal Ig V(L) gene identification and troponin I levels in a phase II trial of risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis |
| Conference Title: | 10th International Symposium on Amyloidosis |
| Journal Title | Amyloid and Amyloidosis |
| Conference Dates: | 2004 Apr 18-22 |
| Conference Location: | Tours, France |
| ISBN: | 9781420037494 |
| Publisher: | CRC Press |
| Date Published: | 2004-01-01 |
| Start Page: | 167 |
| End Page: | 169 |
| Language: | English |
| PROVIDER: | scopus |
| DOI: | 10.1201/9781420037494-59 |
| DOI/URL: | |
| Notes: | Source: Scopus |
